CClinicalTrials.gg
Sign In
Status unknownNCT00206193Updated Oct 30, 2007

Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone

An observational study in Abortion, Induced, sponsored by Atrium Medical Center. Status unknown at 1 site in Netherlands. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2007-10-30.

Sponsored by Atrium Medical Center · Observational

The sponsor has not verified this record recently (last verified Sep 2005), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Time perspective
Prospective
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.

02

Conditions studied

  • Abortion, Induced

Keywords

  • termination of pregnancy
03

In context

Lead sponsor

Atrium Medical Center is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female

Inclusion criteria

  • Pregnant women by whom a termination of pregnancy is desired.

Exclusion criteria

Exclusion Criteria:

  • Women with liver/kidney disease
  • Women on long-term use of corticosteroids (> 6 months)
  • Cardiovascular problems
  • Therapy-resistant diabetic women
  • Therapy-resistant asthma/bronchitis
  • Thalassemia
  • Ulcerative colitis
  • Peptic ulcer disease
  • Glaucoma
  • Porphyria
  • Allergic reaction to prostaglandin or mifepristone
  • Women with a prior caesarian section or women with contractions at the start of the study
05

Study design

Time perspective
Prospective

Interventions

  • Drugmifepristone
  • Drugmisoprostol
  • Drugsulprostone
06

Study locations

1 of 1 sites recruiting
  • Atrium Medisch Centrum
    Heerlen, Limburg, Netherlands
    • Suzanne HW Vonken, Dr. · Contact · 045-5766666(6825)
    • Suzanne HW Vonken, Dr. · Principal investigator
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00206193
Lead sponsor
Atrium Medical Center
First posted
Sep 21, 2005
Last update
Oct 30, 2007

Study contacts

Suzanne HW Vonken, Dr.
Contact
svonken@gmail.com
003145-5766666 ext. 466825
F Roumen, Dr.
Contact
003145-5766666 ext. 466509
F Roumen, Dr.
study director · Atrium Medisch Centrum, Heerlen
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Atrium Medical Center

Start the discussion